Most Recent
ANZ Bank New Zealand has lost its bid to appeal a ruling that common fund orders can be made in class actions, including at an early stage of the proceeding,
US drug maker Pfizer is facing a class action investigation into the possible link between its injectable contraceptive Depo-Provera and brain tumors.
An intellectual property firm has lost its legal challenge to Apple's bid to patent its method of authentication on electronic devices, including smartphones.
Class action settlements leaped in value last year, with three settlements topping the $200 million mark.
Women who were allegedly injured by defective pelvic mesh implants can apply to set aside two approved settlements against Johnson & Johnson and Boston Scientific worth $405 million.
Two Super Retail Group executives' claims that they were unfairly sacked for making whistleblower complaints will go to trial after they lost their bid to enforce an alleged settlement.
Johnson & Johnson has been hit with a class action for allegedly pushing ineffective cold and flu medications containing phenylephrine onto customers for decades.
A class action against Toyota Finance has argued it can add new claims that are out of time because Victorian courts cannot factor in the loss of limitations defences in deciding whether to allow amendments.
Facebook owner Meta has agreed to pay $50 million to settle action by the privacy commissioner over the Cambridge Analytica scandal.
Qantas has reached an agreement to pay $120 million in compensation to 1,800 ground crew staff who were found to have been illegally sacked.